For healthcare providers and informed patients seeking evidence-based nutritional strategies, recent clinical data on pyrroloquinoline quinone offers actionable insights. The compound delivers three distinct therapeutic benefits, each optimized at specific dose ranges: anti-inflammatory effects begin at 5–10 mg daily, making it potentially useful for chronic inflammatory conditions; mitochondrial function enhancement occurs at approximately 20 mg daily, supporting cellular energy production in aging populations; and cognitive improvement, including memory performance, emerges at 10–20 mg daily.
This dose-stratified evidence suggests PQQ may address multiple age-related health concerns simultaneously. Derived from a systematic analysis of human trials, these findings provide a foundation for clinical consideration in metabolic and neurodegenerative health contexts. The modest dosing requirements and natural dietary sources make PQQ an accessible option for individuals seeking to optimize mitochondrial health and cognitive function through nutritional intervention.
Read the full article on GMJ Newsroom.
Was this article helpful?
